Cannabis Watch: GW Pharma’s marijuana-derived epilepsy drug sales continue to climb

Cannabis Watch: GW Pharma’s marijuana-derived epilepsy drug sales continue to climb

GW Pharmaceuticals Inc. reported revenue that topped the consensus estimates Tuesday, as the companys marijuana-derived epilepsy drug continues to grow.
GW Pharma
GWPH, -3.04%
 shares slipped about 0.1% in the extended session.
The company reported a fou…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *